Navigation Links
European Nephrologists Share Insights on the Management of Renal Anemia and Hyperphosphatemia in Latest BioTrends Report
Date:12/1/2008

EXTON, Pa., Dec. 1 /PRNewswire/ -- BioTrends Research Group, Inc. released its third TreatmentTrends(TM): European Nephrology Report. This report runs parallel to two ongoing studies BioTrends conducts -- TreatmentTrends(TM): US and Canadian Nephrology. The report is based on the results of an on-line survey completed by 200 Nephrologists from the UK, Germany, France, Italy, and Spain. The focus is on the management of renal anemia and hyperphosphatemia.

In the ESA market, Amgen's Aranesp is the market share leader in both dialysis and CKD settings and is perceived to have numerous advantages compared to other ESAs. While the use of biosimilar ESAs did increase in the past six months, this was primarily driven by uptake in the German dialysis market. Almost half of the Nephrologists indicate a high concern with the quality of biosimilar ESAs and there appears to be ambivalence about this class of drugs -- only 20% of Nephrologists agree that they have a good understanding of the differences between biosimilar ESAs and their reference brands. Projected ESA share growth is most favorable for Roche's Mircera, particularly in France and Spain, with the greatest share loss coming from Roche's NeoRecormon. Although Aranesp is expected to see share decreases in almost all markets, Nephrologists project Aranesp will maintain its market leader position in both dialysis and CKD.

In general, IV iron is reserved for patients on hemodialysis with about 65% of those treated receiving a consistent maintenance dose. The use of oral iron is more commonplace than the use of IV iron among CKD patients, but many CKD patients do not receive any iron therapy. Venofer and Ferrlecit are the most familiar brands to Nephrologists with market share varying by country. Newcomer Ferinject (ferric carboxymaltose) has yet to make in-roads with 84% of Nephrologists reporting no experience with the drug.

<
'/>"/>
SOURCE BioTrends Research Group, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related biology technology :

1. European EMEA Acceptance of Marketing Authorization Application Filing for SNT-MC17 in Friedreichs Ataxia by Santhera
2. ONCOSCIENCE AG, THE EUROPEAN PARTNER OF YM BIOSCIENCES, ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB
3. YM BIOSCIENCES, EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER
4. Kline Study: Better Brushing Habits Boost European Oral Care Sales
5. Micromet, Inc. to Present at the Sal. Oppenheim 2nd European Healthcare Conference
6. European Centre for Modern Drug Discovery Established in Hamburg
7. SAFC Expands European Commercial Manufacturing and Storage Capacities With $10 Million Investment
8. Cardica Receives European CE Mark for C-Port Flex A System for Use in Coronary Artery Bypass Surgery
9. Biodel Inc. Announces VIAject(TM) Phase II Meal Study Data at the 2007 European Association for the Study of Diabetes Meeting
10. Intellect Neurosciences, Inc. Obtains Validation of European Patent for Alzheimers Vaccine in 19 Countries
11. Pharmion and MethylGene Announce Orphan Drug Designation Granted by the European Medicines Agency (EMEA) for MGCD0103 for the Treatment of Hodgkins Lymphoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)...the National Institute of Standards and Technology...eloped a new way to introduce magnetic impurities ...canning tunneling microscope (STM). Detailed in a ...ers to selectively implant atoms in a crystal one ...ic properties on the atomic scale. , A better un...
(Date:12/4/2009)...LLE, Iowa, Dec. 4 Vivako... that its shareholders of record on December 1, 20...tock of HealthAmerica, Inc. that was previously ap...rica is a private Nevada corporation of which Viva...mon shares on the record date. The distribution da...
(Date:12/4/2009)...ta Centre for Advanced Micro Nano Technology Produ..., , EDMONTON, Dec. 4 /PRNewswire/ - Today ACA...ng how technologies like nanotechnology, biomateri...the creation of innovative healthcare products tha...t and outcomes of patient care, while opening new ...
(Date:12/4/2009)...RK, Dec. 4 Stemline Therapeutics, ...tudies of its IL-3R targeting agents, SL-401 and S...an chronic myeloid leukemia (CML) have been select...nual Meeting of the American Society of Hematology...8, 2009. The poster will be presented by Stemline,...
Breaking Biology Technology:NIST researchers put a new spin on atomic musical chairs 2Vivakor Confirms Record Date of Stock Dividend 2Vivakor Confirms Record Date of Stock Dividend 3Alberta companies delivering new products to the health & medical marketplace 2Stemline Therapeutics Announces Poster Presenting in vivo and Anti-Cancer Stem Cell Activity of SL-401 against Chronic Myeloid Leukemia (CML) at the 51st Annual Meeting of the American Society of Hematology (ASH) 2
... Corporation (Nasdaq: RGEN ) announced today tha...r, Walter C. Herlihy, Ph.D., will present at the B... 9th, 2009 at 11:30 a.m. EST at the Waldorf-Astori...e audio webcast of the presentation will be availa...nd will be archived for 30 days following the pres...
... IPC The Hospitalist Company, Inc. (Nasdaq: IPCM...mpany, announced today that management is schedule...vices Conference held in New York, NY. , , ...erence, Speakers: Adam Sin... Jeff Taylor, President and COO, ...
...em, Inc. (NYSE Alternext US: CUR) announced today ... at the 11th Annual BIO CEO & Investor Confere...orf=Astoria Hotel, New York City. , , (Logo: htt...OGO ) , , Neuralstem,s presentation is scheduled ... Time. , , The presentation will be webcast live ...
Other Biology Technology:Repligen to Present at the BIO CEO & Investor Conference Monday, February 9th, 11:30 a.m. EST 2IPC The Hospitalist Company, Inc. to Present at UBS 2009 Global Healthcare Services Conference 2Neuralstem to Present at the 11th Annual BIO CEO & Investor Conference 2
(Date:12/4/2009)..., The body is a battle zone. Cells constantly com...ugh the manner in which some cells win this compet...est, how stem cells duke it out for space and surv...shed in the October 2 issue of Science by Johns ...his battle by literally sticking around. , "Our ...
(Date:12/4/2009)...UVALDE Dr. Daniel Leskovar, a Texas AgriLife Rese...arch and Extension Center in Uvalde, has been inve...s stressful transition from the greenhouse to the ...l production and possibly even the further profita...uality, more adaptive plants that will establish w...
(Date:12/4/2009)...CORVALLIS, Ore. According to an analysis of state...o made less than $50,000 a year were more than thr...against by health providers because of their insur... addition, reporting of insurance-based discrimina...s with Medicaid coverage, and four times more like...
Breaking Biology News(10 mins):Stem cells battle for space 2Texas AgriLife researchers helping 2Texas AgriLife researchers helping 3Texas AgriLife researchers helping 4Lower income women report more insurance-based discrimination during pregnancy, delivery 2Minnesota Charity Launches Global Initiative to Help Children and Families Fighting Chronic Illnesses 60354 1Minnesota Charity Launches Global Initiative to Help Children and Families Fighting Chronic Illnesses 60354 2Almost 6 Million U S Cases of Swine Flu in First Few Months 60352 1Almost 6 Million U S Cases of Swine Flu in First Few Months 60352 2Almost 6 Million U S Cases of Swine Flu in First Few Months 60352 3Stroke Centers May Offer Best Shot at Recovery 60351 1Stroke Centers May Offer Best Shot at Recovery 60351 2
...lts with autism has provided new evidence that var...l disorder may not communicate with each other as ...ers from the University of Washington,s Autism Cen... Society for Neuroscience on the first study that ...electroencephalography (EEG) to examine connection...
...rican lawmakers, civil rights leaders and medical ...adopt and implement a new blueprint to address the.... The plan is outlined in a new report, African-A...ndations for Confronting the Epidemic in Black Ame...te dean for Community and Minority Affairs and pro...
...dicted poor outcome from traditional radiation and...now has been found to predict a good prognosis wit... making it potentially the first predictive biomar...ntrogen Therapeutics, Inc., in Austin, Texas, foun...oma of the head and neck cancer (SCCHN) whose pre-...
Other Biology News:Brain regions do not communicate efficiently in adults with autism 2New HIV statistics indicate increasing toll of AIDS on African American community 2New HIV statistics indicate increasing toll of AIDS on African American community 3New HIV statistics indicate increasing toll of AIDS on African American community 4Abnormal overexpression of p53 is a predictive molecular biomarker 2
Sheep Anti-Salmonella Thomasville Polyclonal Antibody, Unconjugated from Abcam
Mouse Anti-Drosophila Melanogaster Achaete protein Monoclonal Antibody, Unconjugated from Developmental Studies Hybridoma Bank
Rabbit Anti-OCT6 Polyclonal Antibody, Unconjugated from Abcam
...uper-Sensitive, Super-Dark, Super-Small! Capture ...t images with the ChemiDoc-It Imaging System. High...res, produces low-background noise and wide dynami...e time. The light-tight cabinet provides optimum c...
Biology Products: